.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Future Leaders in Neurology
NMOSD Disease Spotlight
AHS 2022
ATMRD 2022
SLEEP 2022

Clinical FocusSee All >

Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke

Video Series

Cure Connections
Insights
NeurologyLive Peer Exchange
News Network

About Us
Advisory Board
Editorial
Contact Us
Advertise
Contact MJH LS
Do Not Sell My Information
Terms and Conditions
Privacy

Advances in the Diagnosis and Management of Multiple Sclerosis

EP. 1: Diagnosing MS in the Modern Era

February 25th 2019

EP. 2: Early Identification and Diagnosis of MS

February 25th 2019

EP. 3: Diagnostic Tools Used to Identify MS

February 25th 2019

EP. 4: Surrogate Markers for MS

February 25th 2019

EP. 5: Early Initiation of DMTs in MS

February 25th 2019

EP. 6: Appropriateness for Induction Therapy in MS

February 25th 2019

EP. 7: Newer Therapies in MS: Optimized Care

February 25th 2019

EP. 8: Oral Cladribine Therapy for MS

February 25th 2019

EP. 9: Considerations for Using Oral Cladribine in MS

February 25th 2019

EP. 10: Recommendations for Restarting Therapy in MS

February 25th 2019

Latest News

NeurologyLive® Top Expert Interviews: June 2022

Utilizing the Mayo Clinic 3-M Approach for Different Autoimmune Disorder Presentations: Sean Pittock, MD

FDA Accepts BLA for Lecanemab in Alzheimer Disease, Sets PDUFA Date for January 2023

Cure CMD: Benefits of the Annual SciFam Conference

View More News